<?xml version="1.0" encoding="UTF-8"?>
<ref id="R85">
 <label>85</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Xiong</surname>
    <given-names>Z</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ampudia Mesias</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pluhar</surname>
    <given-names>GE</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Cd200 checkpoint reversal: a novel approach to immunotherapy</article-title>. 
  <source>Clin Cancer Res</source>
  <year>2020</year>;
  <volume>26</volume>:
  <fpage>232</fpage>â€“
  <lpage>41</lpage>. 
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-19-2234</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/31624103?>
  <pub-id pub-id-type="pmid">31624103</pub-id>
 </mixed-citation>
</ref>
